Posaconazole responsive cerebral aspergillosis in an immunocompetent adult.

Jonathan Richard Ellenbogen, Mueez Waqar, David W Denning, Richard P D Cooke, Derek W Skinner, Tristram Lesser, Mohsen Javadpour

    Research output: Contribution to journalArticlepeer-review

    Abstract

    Cerebral aspergillosis is a rare manifestation of invasive aspergillosis that usually affects immunocompromised patients. There are few treatment options for recurrent disease and experiences with immunocompetent patients are lacking. We report the clinical course of an immunocompetent patient with recurrent cerebral aspergillosis, following initial treatment with burr hole aspiration and voriconazole, who showed remarkable response to posaconazole. The patient remains clinically well with no evidence of recurrence on MRI 7 years following diagnosis. To our knowledge this is the first reported experience with posaconazole in an immunocompetent patient with cerebral aspergillosis.
    Original languageEnglish
    JournalJournal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia
    Volume21
    Issue number10
    DOIs
    Publication statusPublished - Oct 2014

    Keywords

    • Aspergillosis
    • Central nervous system
    • Immunocompetent
    • Posaconazole
    • Voriconazole

    Fingerprint

    Dive into the research topics of 'Posaconazole responsive cerebral aspergillosis in an immunocompetent adult.'. Together they form a unique fingerprint.

    Cite this